Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Aug 14, 2019, after the close
10-Q filed Aug 14, 2019, 45 days after period end · 0001564590-19-032166
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Revenue | $10.15M | $2.39M |
| Net Income | -$685.00K | -$9.95M |
| EPS Diluted | -$0.07 | -$0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end